ArticleMethodsX2024
An optimized two stage U-Net approach for segmentation of pancreas and pancreatic tumor.
Article in MethodsX, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Artificial intelligence in pancreatic cancer: applications in early detection, tumor staging, and survival prediction-a comprehensive review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Review
- Pancreatic multi structure segmentation on CT using transformer and deep learning approaches.Discover oncology · 2026Article
- Quantitative pancreatic MRI in diabetes mellitus: current advances and future directions.Frontiers in endocrinology · 2026Review
- Multi-class transformer-based segmentation of pancreatic ductal adenocarcinoma and surrounding structures in CT imaging: a multi-center evaluation.Abdominal radiology (New York) · 2026Article
- Applications, image analysis, and interpretation of computer vision in medical imaging.Frontiers in radiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The segmentation of pancreas and pancreatic tumor remain a persistent challenge for radiologists. Consequently, it is essential to develop automated segmentation methods to address this task. U-Net based models are most often used among various deep learning-based techniques in tumor segmentation. This paper introduces an innovative hybrid two-stage U-Net model for segmenting both the pancreas and pancreatic tumors. The optimization technique, used in this approach, involves a combination of meta-heuristic optimization algorithms namely, Grey Wolf Border Collie Optimization (GWBCO) technique, combining the Grey Wolf Optimization algorithm and the Border Collie Optimization algorithm. Our approach is evaluated using key parameters, such as Dice Similarity Coefficient (DSC), Jaccard Index (JI), sensitivity, specificity and precision to assess its effectiveness and achieves a DSC of 93.33 % for pancreas segmentation. Additionally, the model also achieves high DSC of 91.46 % for pancreatic tumor segmentation. This method helps in improving the diagnostic accuracy and assists medical professionals to provide treatment at an early stage with precise intervention. The method offers•Two-stage U-Net model addresses both pancreas and tumor segmentation.•Combination of two metaheuristic optimization algorithms, Grey Wolf and Border Collie for enhanced performance.•High dice similarity coefficient for pancreas and tumor segmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.